home / stock / bti:cc / bti:cc news

BTI:CC News and Press, Bioasis Technologies Inc. From 06/20/23

Stock Information
Company Name: Bioasis Technologies Inc.
Stock Symbol: BTI:CC
Market: TSXVC
Website: bioasis.us
Menu
BTI:CC BTI:CC Quote BTI:CC Short BTI:CC News BTI:CC Articles BTI:CC Message Board
Get BTI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BTI:CC - Bioasis Provides Corporate Update and Announces Suspension of Operations

NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epiderm...
BTI:CC - Bioasis Provides Update on Business Operations

NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth f...

BTI:CC - Bioasis Announces AGM Results and Provides Update on Financial Position

NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epi...

BTI:CC - IIROC Trading Resumption - BTI

IIROC Trading Resumption - BTI Canada NewsWire VANCOUVER, BC , Jan. 23, 2023 /CNW/ - Trading resumes in: Company: Bioasis Technologies Inc. TSX-Venture Symbol: BTI All Issues: Yes Resumption (ET): 10:00 AM IIROC can make a decision to ...
BTI:CC - Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc

NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epi...

BTI:CC - IIROC Trading Halt - BTI

IIROC Trading Halt - BTI Canada NewsWire VANCOUVER, BC , Jan. 23, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Bioasis Technologies Inc. TSX-Venture Symbol: BTI All Issues: Yes Reason: Pending News Halt Time (ET): ...

BTI:CC - Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022

NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epi...
BTI:CC - Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders

NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epi...

BTI:CC - Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc

NEW HAVEN, Conn., Dec. 19, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (OTCQB:BIOAF; TSX.V:BTI) (the “ Company ” or “ Bioasis ”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epi...

BTI:CC - Bioasis Technologies Inc. Announces Shareholder Webinar

NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC . (TSXV:BTI) (OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal ...
Previous 10 Next 10